Chairman Dr Sara Malcus and CEO Peter Olofsson-Sahl participated in the Nordic Life Science days. Reconnecting with several of or ker research partners, analysing potential future CRO provides and advisors for CMC, pre-clinical safety and routes to clinical studies as well as initiating relation with seed investors and corporate finance.

Peter Olofsson- Sahl participated in the @GUventure organised pitching event for investors taking place to specially invited investors in innovative life science technologies at Gothia Tower